The Surrey and Sussex Cancer Alliance Board provides leadership to ensure that all patients with cancer in Surrey and Sussex receive equitable access to safe and effective care.
The Board is founded on the principle of co-design between providers, commissioners, clinicians and service users. It is made up of senior leaders from our local health and care system, charitable organisations and people affected by cancer.
| Member | Role |
|---|---|
| Louise Stead | chair, Surrey and Sussex Cancer Alliance and chief executive, Royal Surrey NHS Foundation Trust |
| Keri Torney | managing director, Surrey and Sussex Cancer Alliance |
| Alex Norman | co-medical director, Surrey and Sussex Cancer Alliance |
| Sarah Westwell | co-medical director, Surrey and Sussex Cancer Alliance |
| Thomas Carter | Macmillan strategic partnership manager for Surrey, Sussex and Kent |
| Helen Raison | consultant in public health, Surrey County Council |
| Jo Hunter | deputy director of recovery, Surrey Heartlands ICB |
| Vaughan Lewis | regional medical director, NHS England/south east |
| Chris Tibbs | medical director commissioning, NHS England/south east |
| Rebecca Furlong | programme manager, NHS England/south east |
| Daniel de Rozarieux | director of Elective Care, Sussex ICB |
| Liz Howells | director of System Planned Care, Frimley ICS |
| Tony Chambers | interim CEO, Queen Victoria Hospital NHS Foundation Trust |
| Julie Smith | CEO, Ashford and St. Peter's Hospitals NHS Foundation Trust |
| Neil Dardis | CEO, Frimley Health NHS Foundation Trust |
| Angela Stevenson | CEO, Surrey and Sussex Healthcare NHS Trust |
| Joe Chadwick-Bell | CEO, East Sussex Healthcare NHS Trust |
| George Findlay | CEO, University Hospitals Sussex NHS Foundation Trust |
| Siobhan O Donnell | programme lead for cancer & diagnostics, Health Education England |
The Clinical Executive acts as the primary source of clinical advice and leadership to the Surrey and Sussex Cancer Alliance Board, across the whole cancer pathway. This extends from prevention strategies, through to screening and early diagnosis; ensuring delivery of evidence based treatment; supporting those living with and beyond cancer, palliative and supportive care; to end of life care. The Clinical Executive comprises the Alliance Clinical Leadership team who assist the Board in improving cancer patients’ outcomes, both in terms of survival and experience of care.
The January 2024 Board Papers are here:
Paper 1 - SSCA Board performance update
Paper 3 - SSCA project status report and budget update
Paper 6 - SSCA public and patient engagement
Paper 7 - NHS England Workforce, Training & Education Directorate update
Certain papers have been omitted as they contain internal information from partner organisations that are not yet in the public domain
Find all the papers here:
Paper 1 - SSCA Board performance update
Paper 2 - SSCA project status report and budget update
Paper 3 - Targeted Lung Health Checks and Targeted Prostate Health Checks update
Paper 4 - Best practice timed pathways and nonspecific symptoms pathways
Paper 5 - Cancer Research UK update
Paper 6 - NHS England Workforce Training and Education Directorate update
The January 2023 Board papers are here:
- Paper 1 - SSCA Board performance update
- Paper 2 - SSCA project status report and planning guidance
- Paper 3 - Targeted lung health check project update
- Paper 4 - Targeted prostate check project update
- Paper 5 - Personalised care project update
- Paper 6 - Radiotherapy Update
- Paper 7 - Health Education England update
- Paper 8 - Cancer Research UK update
- Paper 9 - Cancer Research UK ICB
The April 2022 Board papers are here:
- SSCA Board agenda
- SSCA performance update
- SSCA 21-22 end of year financial summary
- SSCA 22-23 workplan
- South East Cancer Alliances pathway delay and clinical harm review policy
- Macmillan SSCA Board update
- Health Education England SSCA Board update
- NHSEI South East England regional team SSCA Board update